§ 1.
stoffer som er oppført på særskilt liste (dopinglisten) salter av disse stoffer og mulige stereoisomere, estere og etere av stoffene og deres salter blandinger som inneholder stoffer nevnt i bokstav a og b.
Forskrift om hva som skal anses som dopingmidler
§ 2.
§ 3.
legemidlene er rekvirert av lege eller tannlege, den reisende kan dokumentere, for eksempel ved hjelp av pakningens etikett, resept eller legeerklæring, at legemidlene er rekvirert til eget personlig, medisinsk bruk, og mengden medbrakt legemiddel ikke overstiger 30 dagers forbruk i henhold til angitt dosering.
Dopingliste
| Stoffnavn | Kjemisk navn | CAS-nummer |
|---|---|---|
| adrafinil | (±)-2-benzhydrylsulfinyletanhydroksaminsyre | 63547-13-7 |
| adrenalin, epinefrin | (R)-4-(1-hydroksy-2-(metylamino)etyl)benzen-1,2-diol | 51-43-4 |
| amifenazol | 5-fenyl-1,3-thiazol-2,4-diamin | 490-55-1 |
| androsteron | 3α-hydroksy-5α-androstan-17-on | 53-41-8 |
| – | 5α-androstan-3α,17α-diol | 6165-21-5 |
| hombreol | 5α-androstan-3α,17β-diol | 1852-53-5 |
| – | 5α-androstan-3β,17α-diol; 3β,17α-dihydroksy-5α-androstan | – |
| 3β-androstandiol | 5α-androstan-3β,17β-diol | 571-20-0 |
| androstendiol, 5-androstendiol | androst-5-en-3β,17β-diol | 521-17-5 |
| – | androst-4-en-3α,17α-diol | – |
| – | androst-4-en-3α,17β-diol; 4-androsten-3α,17β-diol | 1852-61-5 |
| – | androst-4-en-3β,17α-diol | – |
| – | androst-5-en-3α,17α-diol | 47122-33-8 |
| – | androst-5-en-3α,17β-diol | – |
| – | androst-5-en-3β,17α-diol; androst-5-en-3,17-diol, (3β,17α)- | 1963-03-7 |
| 1-androstendiol | 5α-androst-1-en-3β,17β-diol | 5323-27-3 |
| 4-androstendiol | androst-4-en-3β,17β-diol | 1156-92-9 |
| androstendion, 4-androstendion | androst-4-en-3,17-dion | 63-05-8 |
| 1-androstendion | 5α-androst-1-en-3,17-dion | 571-40-4 |
| 5-androstendion | androst-5-en-3,17-dion | 571-36-8 |
| bitolterol | (RS)-[4-(1-hydroksy-2-tert-butylamino-etyl)-2-(4-metylbenzoyl)oxy-fenyl] 4-metylbenzoat | 30392-40-6 |
| bolandiol | 19-norandrostendiol; 19-nor-4-androstendiol; estr-4-en-3β,17β-diol; 3β-dihydronandrolon | 19793-20-5 |
| bolasteron | 7α,17α-dimetyltestosteron | 1605-89-6 |
| boldenon, 1-dehydrotestosteron | androsta-1,4-dien-17β-ol-3-on | 846-48-0 |
| boldion, androstadiendion, 1-dehydroandrostendion | androsta-1,4-dien-3,17-dion; 1,4-androstadien-3,17-dion | 897-06-3 |
| bromantan, bromontan, adamantylbromfenylamin | N-(4-bromofenyl)adamantan-2-amin | 87913-26-6 |
| cyclazodon | (RS)-2-(syklopropylamino)-5-fenyl-1,3-oxazol-4-on | 14461-91-7 |
| danazol | 17α-etynyl-17β-hydroksyandrost-4-eno[2,3-d]isoksazol | 17230-88-5 |
| dehydroklormetyltestosteron, klorodehydrometyltestosteron | 4-klor-17β-hydroksy-17α-metylandrosta-1,4-dien-3-on | 2446-23-3 |
| desoksymetyltestosteron, DMT | 17α-metyl-5α-androst-2-en-17β-ol | 3275-64-7 |
| DHEA (dehydroepiandrosteron, prosteron), androstenolon | androst-5-en-3β-ol-17-on; 3β-hydroksyandrost-5-en-17-on | 53-43-0 |
| dihydrotestosteron, DHT, 5α-dihydrotestosteron, 5α-DHT, androstanolon, stanolon | 17β-hydroksy-5α-androstan-3-on; 5α-androstan-17β-ol-3-on | 521-18-6 |
| dobutamin | (RS)-4-(2-{[4-(4-hydroksyfenyl)butan-2-yl]amino}etyl)benzen-1,2-diol | 34368-04-2 |
| doksapram | 1-etyl-4-(2-morfolin-4-yletyl)-3,3-difenyl-pyrrolidin-2-on | 309-29-5 |
| dopamin, DA | 3,4-dihydroksyfenetylamin | 51-61-6 |
| drostanolon, dromostanolon | 2α-metyl-4,5α-dihydrotestosteron; 2α-metyl-5α-androstan-17β-ol-3-on | 58-19-5 |
| efedrin | rel-(R,S)-2-(metylamino)-1-fenylpropan-1-ol | 299-42-3 |
| epiandrosteron, isoandrosteron | 3β-hydroksy-5α-androstan-17-on; 3β-androsteron; 5α-androstan-3β-ol-17-on | 481-29-8 |
| epi-dihydrotestosteron, 17-epi-dihydrotestosteron | 17α-hydroksy-5α-androstan-3-on | 571-24-4 |
| erytropoietin (EPO), erytropoetin, hematopoietin, hemopoietin | ||
| etafedrin, etylefedrin | (1R,2S)-2-[etyl(metyl)amino]-1-fenyl-1-propanol | 48141-64-6 |
| etamivan | N,N-dietyl-4-hydroksy-3-metoksybenzamid | 304-84-7 |
| etilefrin | (2-etylamino-1-(3'-hydroksy-fenyl)etanol; (RS)-3-[2-(etylamino)-1-hydroksyetyl]fenol | 709-55-7 |
| etyløstrenol, etylnandrol | 19-nor-17α-pregn-4-en-17-ol | 965-90-2 |
| famprofazon | 1-metyl-5-{[metyl(1-fenylpropan-2-yl)amino]metyl}-2-fenyl-4-(propan-2-yl)-1,2-dihydro-3H-pyrazol-3-on | 22881-35-2 |
| fenbutrazat | 2-(3-metyl-2-fenylmorfolin-4-yl)etyl 2-fenylbutanoat | 4378-36-3 |
| fenkamin | 1,3,7-trimetyl-8-({2-[metyl(1-fenylpropan-2-yl)amino]etyl}amino)-3,7-dihydro-1H-purin-2,6-dion | 28947-50-4 |
| fenoterol | (RR,SS)-5-(1-hydroksy-2-{[2-(4-hydroksyfenyl)-1-metyletyl]amino}etyl)benzen-1,3-diol | 130156-24-0 |
| fenprometamin | N-metyl-2-fenylpropan-1-amin | 93-88-9 |
| fenylpropanolamin, PPA | (1R,2S)-2-amino-1-fenylpropan-1-ol | 14838-15-4 |
| fluoksymesteron, androfluoren | 9α-fluor-11β-hydroksy-17α-metyltestosteron; 9α-fluor-17α-metylandrost-4-en-11β,17β-diol-3-on | 76-43-7 |
| formebolon, formyldienolon | 2-formyl-11α-hydroksy-17α-metyl-δ1-testosteron | 2454-11-7 |
| furazabol, androfurazanol | 17α-metyl-5α-androsta[2,3-c]furazan-17β-ol | 1239-29-8 |
| furfenoreks | furfurylmetylamfetamin | 3776-93-0 |
| gestrinon, etylnorgestrienon | 17α-etynyl-18-metylestra-4,9,11-trien-17β-ol-3-on | 16320-04-0 |
| gonadotropiner (LH, hCG) | ||
| heptaminol | (RS)-6-amino-2-metylheptan-2-ol | 372-66-7 |
| 4-hydroksytestosteron, 4-OHT | 4,17β-dihydroksyandrost-4-en-3-on | 2141-17-5 |
| isomethepten | N,6-dimetylhept-5-en-2-amin | 503-01-5 |
| isoprenalin, isoproterenol | (RS)-4-[1-hydroksy-2-(isopropylamino)etyl]benzen-1,2-diol | 7683-59-2 |
| kalusteron | 7β,17α-dimetyltestosteron | 17021-26-0 |
| karfedon, fenylpiracetam, fonturacetam | (R,S)-2-(2-okso-4-fenylpyrrolidin-1-yl)acetamid | 77472-70-9 |
| klenbuterol | (RS)-1-(4-amino-3,5-diklorfenyl)-2-(tert-butylamino)etan-1-ol | 37148-27-9 |
| klorprenalin | 1-(2-klorfenyl)-2-(propan-2-ylamino)etanol | 3811-25-4 |
| klostebol, 4-klortestosteron, klorotestosteron | 4-klorandrost-4-en-17β-ol-3-on | 1093-58-9 |
| kropropamid | 2-[[(E)-but-2-enoyl]-propylamino]-N,N-dimetylbutanamid | 633-47-6 |
| krotetamid | 2-[[(E)-but-2-enoyl]-etylamino]-N,N-dimetylbutanamid | 6168-76-9 |
| kvinbolon | 1-dehydrotestosteron 17β-cyclopent-1-enyl eter | 2487-63-0 |
| LGD-4033, ligandrol | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroksyetyl]pyrrolidin-1-yl]-2-(trifluorometyl)benzonitril | 1165910-22-4 |
| mekano vekstfaktorer (MGFs) | ||
| meklofenoksat, sentrofenoksin | 2-dimetylaminoetyl (4-klorfenoksy)acetat | 51-68-3 |
| mestanolon, metylandrostanolon | 17α-metyl-4,5α-dihydrotestosteron | 521-11-9 |
| mesterolon | 1α-metyl-4,5α-dihydrotestosteron | 1424-00-6 |
| metandienon, metandrostenolon | 17β-hydroksy-17α-metylandrosta-1,4-dien-3-on; 17α-metylandrost-1,4-dien-17β-ol-3-on | 72-63-9 |
| metandriol, metylandrostendiol, metyl-5-androstendiol | 17α-metylandrost-5-en-3β,17β-diol | 521-10-8 |
| metaraminol, metaradrin | (1R,2S)-3-[-2-amino-1-hydroksy-propyl]fenol | 54-49-9 |
| metasteron, metyldrostanolon | 2α,17α-dimetyl-4,5α-dihydrotestosteron | 3381-88-2 |
| metenolon, metylandrostenolon | 1-metyl-5α-androst-1-en-17β-ol-3-on | 153-00-4 |
| metoksyfenamin, 2-metoksy-N-metylamfetamin | 1-(2-metoksyfenyl)-N-metylpropan-2-amin | 93-30-1 |
| metyldienolon | 17α-metyl-19-nor-δ9-testosteron; 17α-metylestra-4,9-dien-17β-ol-3-on | 14531-89-6 |
| metylefedrin, N-metylefedrin | (1R,2S)-2-(dimetylamino)-1-fenyl-1-propanol | 552-79-4 |
| metylnortestosteron, 11β-metyl-19-nortestosteron, 11β-MNT | 11β-metylestr-4-en-17β-ol-3-on | 18046-77-0 |
| metyltestosteron, 17α-metyltestosteron | 17α-metylandrost-4-en-17β-ol-3-on | 58-18-4 |
| metyl-1-testosteron, 17α-metyl-1-testosteron, M1T, metyldihydroboldenon | 17β-hydroksy-17α-metyl-5α-androst-1-en-3-on; 17α-metyl-5α-androst-1-en-17β-ol-3-on | 65-04-3 |
| metyltrienolon, metribolon | 17α-metylestra-4,9,11-trien-17β-ol-3-on | 965-93-5 |
| miboleron, dimetylnortestosteron, DMNT | 7α,17α-dimetyl-19-nortestosteron | 3704-09-4 |
| nandrolon, 19-nortestosteron | estr-4-en-17β-ol-3-on; 19-norandrost-4-en-17β-ol-3-on | 434-22-0 |
| niketamid, nikotinsyre dietylamid | N,N-dietyl-3-pyridinkarboksamid | 59-26-7 |
| noradrenalin (NA), norepinefrin (NE) | (R)-4-(2-amino-1-hydroksyetyl)benzen-1,2-diol | 51-41-2 |
| 19-norandrostendion, bolandion | estr-4-en-3,17-dion; 19-norandrost-4-en-3,17-dion | 734-32-7 |
| 19-norandrosteron | 5α-estran-3α-ol-17-on; 3α-hydroksy-5α-estran-17-on | 1225-01-0 |
| norboleton | 17α-etyl-18-metyl-19-nortestosteron | 1235-15-0 |
| noretandrolon, 3-ketoetylestrenol, etylestrenolon | 17α-etyl-19-nortestosteron | 52-78-8 |
| 19-noretiokolanolon | 5β-estran-3α-ol-17-on | 33036-33-8 |
| norklostebol | 4-klorestr-4-en-17β-ol-3-on | 13583-21-6 |
| oksabolon | 4-hydroksy-19-nortestosteron | 4721-69-1 |
| oksandrolon | 17α-metyl-2-oksa-4,5α-dihydrotestosteron | 53-39-4 |
| oksilofrin, metylsynefrin, hydroksyefrin, oksyefrin, 4-HMP | (1S*,2R*)-(±)-4-(1-hydroksy-2-metylamino-propyl)fenol | 365-26-4 |
| oksymesteron, metandrostendiolon | 4-hydroksy-17α-metyltestosteron; 17α-metylandrost-4-en-4,17β-diol-3-on | 145-12-0 |
| oksymetolon | 2-hydroksymetylen-17α-metyl-4,5α-dihydrotestosteron | 434-07-1 |
| oktopamin, para-oktopamin | para-hydroksy-fenyl-etanolamin; (RS)-4-(2-amino-1-hydroksy-etyl)fenol | 104-14-3 |
| orciprenalin, metaproterenol | (RS)-5-[1-hydroksy-2-(isopropylamino)etyl]benzen-1,3-diol | 586-06-1 |
| ortetamin, 2-metylamfetamin | (±)-1-(2-metylfenyl)propan-2-amin | 5580-32-5 |
| ostarin, enobosarm, MK-2866 | ((2S)-3-(4-cyanofenoksy)-N-[4-cyano-3-(trifluorometyl)fenyl]-2-hydroksy-2-metylpropanamid | 841205-47-8 |
| pentetrazol, pentylentetrazol, metrazol, pentametylentetrazol | 6,7,8,9-tetrahydro-5H-tetrazolo(1,5-a)azepin | 54-95-5 |
| prasteron (dehydroepiandrosteron, DHEA) | androst-5-en-3β-ol-17-on; 3β-hydroksyandrost-5-en-17-on | 53-43-0 |
| prenalterol | 4-{[(2S)-2-hydroksy-3-(isopropylamino)propyl]oxy}fenol | 57526-81-5 |
| prolintan | 1-(1-fenylpentan-2-yl)pyrrolidin | 493-92-5 |
| propylheksedrin, heksahydro-metamfetamin | (±)-1-sykloheksyl-N-metylpropan-2-amin | 101-40-6 |
| prostanozol, demetylstanozolol tetrahydropyran eter | 17α-demetylstanozolol 17β-tetrahydropyran eter | 1186001-41-1 |
| RAD140, testolon | 2-klor-4-{[(1R,2S)-1-[5-(4-cyanofenyl)-1,3,4-oxadiazol-2-yl]-2-hydroksypropyl]amino}-3-metylbenzonitril | 1182367-47-0 |
| rimiterol | 4-{(S)-hydroksy[(2R)-piperidin-2-yl]metyl}benzen-1,2-diol | 32953-89-2 |
| sibutramin | 1-(1-(4-klorfenyl)syklobutyl)-N,N,2,2-tetrametylpropan-1-amin | 106650-56-0 |
| somatropin/hGh, hGH, HGH, GH | ||
| stanozolol, androstanazol, stanazol | 17α-metyl-2'H-5α-androst-2-eno[3,2-c]pyrazol-17β-ol | 10418-03-8 |
| stenbolon | 2-metyl-5α-androst-1-en-17β-ol-3-on | 5197-58-0 |
| stryknin | stryknidin-10-on | 57-24-9 |
| testosteron | 17β-hydroksyandrost-4-en-3-on; androst-4-en-17β-ol-3-on | 58-22-0 |
| 1-testosteron, δ1-dihydrotestosteron, dihydroboldenon | 17β-hydroksy-5α-androst-1-en-3-on | 65-06-5 |
| tetrahydrogestrinon, THG | 18a-homo-pregna-4,9,11-trien-17β-ol-3-on; 17α-etyl-18-metylestra-4,9,11-trien-17β-ol-3-on | 618903-56-3 |
| tibolon | 7α-metyl-19-nor-17α-pregn-5(10)-en-20-yn-17-ol-3-on | 5630-53-5 |
| trenbolon, trienolon, trienbolon | estra-4,9,11-trien-17β-ol-3-on | 10161-33-8 |
| vekstfaktorer – insulinlignende (eks. IGF-1), somatomedin C | ||
| veksthormon/hGh, somatotropin | ||
| zeranol, α-zeralanol, zeralanol | (3S,7R)-7,14,16-trihydroksy-3-metyl-3,4,5,6,7,8,9,10,11,12-dekahydro-1H-2-benzoksasyclotetradekin-1-on | 26538-44-3 |
| zilpaterol | (±)-trans-4,5,6,7-tetrahydro-7-hydroksy-6-(isopropylamino)-imidazo[4,5,1-jk]-[1]benzazepin-2(1H)-on | 119520-05-7 |
Tekst: Lovdata (offentleg eigedom, jf. åndsverkloven § 14), gjengitt uendret per siste tilgjengelige versjon. Rettsregels lovkommentarer er tydelig merket og er våre egne.